OpenAI IPO filing preparations & AI makes a new math proof - Tech News (May 21, 2026)

Let’s start with the biggest business headline: OpenAI is reportedly preparing to confidentially submit a draft IPO prospectus to U.S. regulators, possibly as soon as Friday. Major banks are said to be involved, but the timeline could still slide. If this proceeds, it’s a turning point for the company that helped ignite the current AI wave—and it would also force unusually bright public scrutiny onto OpenAI’s finances, growth story, and cash burn, right as competition heats up in enterprise and coding tools.

And OpenAI isn’t only in the spotlight for markets. The company also says a new reasoning model produced an original proof that disproves a well-known discrete geometry conjecture posed by Paul Erdős back in 1946. What makes this notable is the context: OpenAI previously took criticism after an earlier, high-profile math claim didn’t hold up. This time, it’s pointing to supportive remarks from respected mathematicians, and the result—if broadly validated—adds weight to the idea that AI can contribute to genuine, new research rather than just remix what’s already known.

Staying with AI for science, researchers at Google published a system in Nature called ERA—short for Empirical Research Assistance—that can generate and refine scientific software by trying many variations and keeping what scores best. The headline isn’t that it writes code; it’s that it can iteratively improve research programs in domains where you can measure success, like better predictions or tighter model fits. If tools like this generalize, they could shift scientists away from weeks of tuning and toward choosing better questions and experiments.

Along similar lines, two separate “AI co-scientist” systems in Nature are pushing the idea of multi-agent workflows for biomedical research—systems that can draft hypotheses, propose experiments, and summarize literature, with humans still deciding what to test and running the actual lab work. Early demonstrations surfaced drug candidates for diseases like acute myeloid leukaemia and dry age-related macular degeneration. No one’s claiming these are finished medicines, but the promise is speed: compressing some early discovery steps from weeks into hours, then letting reality in the lab do the filtering.

Now, a study out of UC San Diego is adding fuel to a different debate: whether chatbots can convincingly pass as humans. In a classic three-party Turing-style setup, researchers found that modern models were judged to be the human a majority of the time—especially when prompted to adopt a specific persona. The bigger takeaway is about risk: if “humanlike” performance can be dialed up with the right prompting, it gets easier to deploy believable bots for manipulation, fraud, and social engineering in everyday online spaces.

That concern ties neatly to the growing push for content labeling. Google says its SynthID watermarking system has now labeled an enormous amount of AI-generated media and—more importantly—it’s expanding beyond Google’s own models. Partners are expected to include major players across the AI stack, which matters because watermarking only becomes truly useful when it’s widely adopted. It won’t solve everything—unmarked content will still circulate—but it’s a clear signal that big platforms are preparing for a world where “prove this is real” becomes a normal user question.

Switching to the labor side of the AI boom, Meta carried out a significant round of layoffs as part of a restructuring, while also shifting thousands of employees into AI-focused roles. The message from leadership is that this is about competing in an AI-led industry, even if it’s painful in the short term. In a separate and more provocative note, Cloudflare’s CEO wrote that his company cut a large share of staff despite strong growth—arguing that AI changes how companies should be organized, not just how productive individuals can be. Read together, it’s a reminder that “AI transformation” increasingly means redesigning teams, not simply buying new software.

On the geopolitics and policy front, Singapore signed separate AI agreements with Google and OpenAI aimed at accelerating AI deployment across public services and business. OpenAI plans to set up an applied AI lab in Singapore, while Google’s partnership emphasizes training and research collaboration. Singapore is positioning itself as a neutral, talent-dense platform for developing and deploying AI globally—and these deals are a concrete step in that direction.

Now for security: GitHub says an attacker accessed and exfiltrated thousands of GitHub-internal repositories after an employee installed a trojanized Visual Studio Code extension. GitHub says it contained the incident quickly and hasn’t found evidence that customer data outside the affected repos was accessed. Still, it’s another blunt reminder that developer tools are part of the attack surface—extensions, plugins, and marketplaces can be a fast path to high-value code if one compromised install slips through.

In consumer tech, Apple is expected to add new privacy controls to a future Siri upgrade, including automatic deletion of Siri conversation history after a chosen period. That’s a small setting with big implications: as people share more sensitive information with assistants, retention defaults start to matter as much as the assistant’s accuracy. Apple is betting that explicit user choice—and tighter data minimization—can be a differentiator in the assistant wars.

Also from the Apple rumor mill: a leak claims Apple’s foldable iPhone has reached trial production and may have achieved a display that looks nearly crease-free, but that hinge durability is still failing internal standards. If accurate, it flips the usual narrative. The screen may be the easy part now; the hinge is the real gatekeeper for whether a foldable ships on schedule.

On the bio side, de-extinction company Colossal Biosciences is drawing fresh attention—and criticism—after promoting breakthroughs tied to artificial egg tech for large birds, alongside separate claims of nearing an artificial-womb system for mammals. Scientists in New Zealand are questioning feasibility, the lack of peer-reviewed disclosure around some claims, and the broader ethics of creating hard-to-reverse systems without strong oversight. At the same time, even skeptics acknowledge a potential upside: tools developed for “de-extinction” could end up being more valuable for conservation, like improving hatching success or genetic diversity for endangered species.

In medical research, UCLA scientists reported preclinical progress on a “cytokine-armored” CAR-T approach against aggressive glioblastoma in mouse models, aiming to boost tumor control while managing toxicity. Glioblastoma is notoriously difficult, and CAR-T has struggled in solid tumors, so any credible path that improves effectiveness without dangerous side effects is worth watching. This is still early-stage, but it’s the kind of careful iteration that could open doors to first-in-human trials down the line.

Finally, one for the open-source and consumer hardware world: a long-running legal dispute over Vizio smart TVs is headed to a California jury trial later this year. The core issue is whether Vizio provided complete, buildable source code for components under copyleft licenses like the GPL and LGPL. A ruling here could have ripple effects for Linux-based consumer devices—impacting not just compliance norms, but also what owners can realistically do with hardware they already bought, from privacy tweaks to long-term maintenance.

And before we wrap, a notable correction of expectations: Jeff Bezos said his stealth startup Project Prometheus has nothing to do with robotics, despite how it’s often described. Instead, he framed it as building an “artificial general engineer” for designing physical objects—think next-generation design tools rather than robot bodies. If that vision lands, it could influence everything from manufacturing workflows to aerospace design, and it helps explain why Bezos is personally spending serious time on it.